Christopher D'Angelo, MD
Dr. Christopher D'Angelo is an Assistant Professor within the Hematology/Oncology Division at the University of Nebraska Medical Center in Omaha, NE. After graduating with a B.S. from Northwestern University in 2008, he attended the University of Illinois College of Medicine from 2009-2013 and graduated with honors. He completed a residency in Internal Medicine at the University of Chicago, Chicago, IL in 2016, followed by a hematology/oncology fellowship at the University of Wisconsin, Madison, WI in 2019. Dr. D'Angelo's clinic focuses on patients with lymphoma and multiple myeloma, and he attends on the bone marrow transplant service regularly. Dr. D'Angelo's research interests include clinical trials in lymphoma and multiple myeloma as well as translational research with collaborative partners investigating the role of the gut microbiome in the pathogenesis and treatment of lymphoma and multiple myeloma.
Financial relationships
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Bristol Myers SquibbTopic:research fundingDate added:01/14/2024Date updated:01/14/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Fate TherapeuticsTopic:research fundingDate added:01/14/2024Date updated:01/14/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:BeigeneTopic:research fundingDate added:01/14/2024Date updated:01/14/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Ono Pharma IncTopic:research fundingDate added:01/14/2024Date updated:01/14/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Ono PharmaTopic:advisory board meetingDate added:01/14/2024Date updated:01/14/2024Relationship end date:12/09/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Bristol Myers SquibbTopic:advisory board meetingDate added:01/14/2024Date updated:01/14/2024Relationship end date:12/09/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:SeagenTopic:advisory board meetingDate added:01/14/2024Date updated:01/14/2024Relationship end date:08/31/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:AbbvieTopic:consultantDate added:01/14/2024Date updated:01/14/2024Relationship end date:12/31/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Curis IncTopic:research fundingDate added:01/14/2024Date updated:01/14/2024